Positron Emission Tomography (PET) is a highly sensitive imaging modality particularly useful in oncology imaging.
Spinal angiography remains a highly sensitive imaging modality to exclude multiplicity.
Positron emission tomography is a highly sensitive imaging modality, with which we have had great success in tracking SCKs in vivo.
PET is a highly sensitive imaging modality that requires only a trace amount of probes (nanograms), whereas MRI requires a relatively high amount of contrast agent (micrograms to milligrams) [ 4].
Compression ultrasonography has proven to be a highly sensitive and specific modality for the recognition of lower extremity deep vein thrombosis (DVT).
Point-of-care ultrasound for the detection of SCFE is a highly sensitive, non-ionizing imaging modality.
Low-dose computed tomography (CT) is a highly sensitive and specific diagnostic modality for detecting stones in the urinary tract, but because of the radiation exposure it should be considered as a last-line test during pregnancy [14, 15, 16].
PET is a highly sensitive and quantitative imaging modality and could become a useful imaging tool for studying the in vivo fate of graphene-based nanomaterial after radiolabeling.
FDG-PET/CT is a highly sensitive, specific and useful modality for providing good anatomic and functional localization of sites of recurrence and distant metastasis in the preclinical stage before it becomes evident by conventional imaging modalities.
